Benzinga | May 6, 2021 04:56PM EDT

Fulgent Genetics Q1 Adj. EPS $6.59 Beats $5.86 Estimate, Sales $359.40M Beat $321.51M Estimate; Raises Guidance

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $6.59 per share which beat the analyst consensus estimate of $5.86 by 12.46 percent. This is a 22066.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $359.40 million which beat the analyst consensus estimate of $321.51 million by 11.79 percent. This is a 4.54K percent increase over sales of $7.75 million the same period last year.